ARS Pharmaceuticals, Inc. (SPRY)
NasdaqGM · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
ARS Pharmaceuticals, Inc. is trading at $3.38, down 7.79% on the session. The 50 day average sits at $4.57 and the 200 day at $7.39, which puts the stock in a downtrend. RSI is at 29.8, which reads as oversold, and MACD is bearish crossover. Volume is average.
The nearest support is around $3.34 with resistance near $4.44, so that band frames the current range. Average daily movement is roughly $0.28, or about 8.2% of the share price, which is what any stop placement has to allow for. The overall health score of 20 out of 100 combines a trend score of 0, momentum of 28 and a risk score of 42.
Technical indicators
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Company website